About Us

Our team is committed to enhancing our understanding of human disease.


Transforming the measurement of disease progression in vivo using noninvasive biosensors.


Bioengineered, tunable sensors that are designed for each protease-mediated disease.


Evolving the way diseases are understood, tracked and treated to accelerate the development of drugs.

News & Events

Transforming the way diseases are detected, tracked, treated, and understood.


Leveraging the profound advances in engineering, medicine, biotechnology, and machine learning.

Contact Us

We are proud to be members of the pre-eminent Cambridge biotech community.


Glympse Bio has a proven, flexible and customizable technology platform – powered by a highly scalable product engine – that can be deployed in multiple markets and applications.

Best of all, our platform comes packaged in a favorable device regulatory pathway and drug reimbursement model. We are excellent collaborators who consistently deliver for partners that share our vision and passion for changing the way treatments are developed, healthcare is delivered, and patients are diagnosed, treated, and monitored. Together, we can do this and enhance value for our partners and ourselves.

Join forces to change the way treatments are developed